Literature DB >> 26757848

Comparative assessment of humoral immune responses of aluminum hydroxide and oil-emulsion adjuvants in Influenza (H9N2) and Newcastle inactive vaccines to chickens.

Mahdie Jafari1, Masoud Moghaddam Pour2, Morteza Taghizadeh2, Shahin Masoudi3, Zahra Bayat1.   

Abstract

Context Adjuvants are compounds used in the preparation of inactive vaccines to enhance the immune response. Aluminum hydroxide (alum) is one of the first compounds approved by the Food and Drug Administration, which is used as adjuvants in vaccine products for humans. Montanide ISA 70 is an oil-emulsion adjuvant and is used in poultry inactive vaccines. Objective In this study, the effects of alum adjuvant on the efficiency and induction of immune response in inactive vaccines of Influenza and Newcastle are compared with those of ISA 70. Materials and methods Six groups of 7-d-old specific-pathogen-free chickens were inoculated with 0.3 ml of the prepared vaccines via the subcutaneous route in the neck. Immune response in each group after 7, 14, 21, 31, 41, and 45 d was evaluated using the technique of hemagglutination inhibition. Results The results were compared using SPSS software. Results showed that vaccines containing adjuvant ISA 70 depicted a higher increase in the immune response and adjuvant of 20% alum is similar to adjuvant of ISA 70 in boosting the immune system. There was no statistically significant difference between 10% and 20% alum, but these adjuvants are visibly different from ISA 70. Conclusion In conclusion, alum can be used as an easily accessible, harmless, and effective adjuvant; however, to increase the immune period using the inactive vaccines for poultry, more research would be necessary.

Entities:  

Keywords:  Adjuvant; aluminum hydroxide; humoral immune responses; influenza (H9N2) and Newcastle vaccines; montanide ISA70

Mesh:

Substances:

Year:  2016        PMID: 26757848     DOI: 10.3109/21691401.2015.1129626

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  7 in total

1.  Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs.

Authors:  Joseph R Francica; Daniel E Zak; Caitlyn Linde; Emilio Siena; Carrie Johnson; Michal Juraska; Nicole L Yates; Bronwyn Gunn; Ennio De Gregorio; Barbara J Flynn; Nicholas M Valiante; Padma Malyala; Susan W Barnett; Pampi Sarkar; Manmohan Singh; Siddhartha Jain; Margaret Ackerman; Munir Alam; Guido Ferrari; Andres Salazar; Georgia D Tomaras; Derek T O'Hagan; Alan Aderem; Galit Alter; Robert A Seder
Journal:  Blood Adv       Date:  2017-11-17

2.  Formulation of HBs antigen in Montanide ISA266 shows superiority to commercial HBsAg vaccine in the induction of humoral immune responses.

Authors:  Mohammad Ali Savoji; Setareh Haghighat; Mina Mirzaee; Bahareh Golkaran; Rayhaneh Mirzaee; Behzad Esfandiari; Mehdi Mahdavi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019

3.  Comparative safety and efficacy of two bivalent vaccines containing Newcastle disease LaSota and avian influenza H9N2 Sidrap isolate formulated with different oil adjuvants.

Authors:  Jossie Intan Cahyani; Sitarina Widyarini; Michael Haryadi Wibowo
Journal:  Vet World       Date:  2020-11-24

4.  CAvant® WO-60 as an Effective Immunological Adjuvant for Avian Influenza and Newcastle Disease Vaccine.

Authors:  Eun-Seo Lee; Young-Jung Shim; W A Gayan Chathuranga; Young-Hoon Ahn; In-Joong Yoon; Sung-Sik Yoo; Jong-Soo Lee
Journal:  Front Vet Sci       Date:  2021-12-03

5.  Gamma-Irradiated Fowl Cholera Mucosal Vaccine: Potential Vaccine Candidate for Safe and Effective Immunization of Chicken Against Fowl Cholera.

Authors:  Bereket Dessalegn; Molalegne Bitew; Destaw Asfaw; Esraa Khojaly; Saddam Mohammed Ibrahim; Takele Abayneh; Esayas Gelaye; Hermann Unger; Viskam Wijewardana
Journal:  Front Immunol       Date:  2021-11-30       Impact factor: 7.561

6.  Recombinant hemagglutinin of swine H1N1 influenza virus expression in the insect cells: Formulation in Montanide ISA71 adjuvant and the potency studies.

Authors:  Sara Zahmati; Morteza Taghizadeh; Setareh Haghighat; Reza Jalalirad; Mehdi Mahdavi
Journal:  Iran J Basic Med Sci       Date:  2021-11       Impact factor: 2.699

7.  Application of red clover isoflavone extract as an adjuvant in mice.

Authors:  Hongbo Chen; Xue Zhang; Longsi Liu; Mingqin Cai; Zhijun Guo; Longxin Qiu
Journal:  Exp Ther Med       Date:  2019-12-11       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.